Any adverse event (combined: diarrhoea, urinary tract infection, falls, dizziness, agitations) · Apathy in people with mild‐to‐moderate Alzheimer's disease
Omega‐3 PUFA supplements showed no clear difference in any adverse event (combined: diarrhoea, urinary tract infection,… compared with placebo (moderate certainty).
1 finding from 1 review
ADL outcome · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Overall dementia severity (cognition and function combined) · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Memory ‐ not measured · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events "Defined as events that result in death, hospitalization, prolongation of hospitalization, or are life threatening (based on the judgment of the study physician)" (Quinn 2010) · Apathy in people with mild‐to‐moderate Alzheimer's disease
Omega‐3 PUFA supplements showed no clear difference in serious adverse events "Defined as events that result in death,… compared with placebo (high certainty).
1 finding from 1 review
QoL · Apathy in people with mild‐to‐moderate Alzheimer's disease
2 findings from 1 review
Depressive symptoms · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Mental health outcomes · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Cognitive function · Apathy in people with mild‐to‐moderate Alzheimer's disease
2 findings from 1 review
IADL · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review